{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:07:33Z","timestamp":1768039653762,"version":"3.49.0"},"reference-count":40,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,3,1]]},"DOI":"10.1185\/030079906x167462","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T00:03:42Z","timestamp":1170893022000},"page":"495-503","source":"Crossref","is-referenced-by-count":69,"title":["Acute coronary syndromes in Europe: 1-year costs and outcomes"],"prefix":"10.1185","volume":"23","author":[{"given":"Matthew J.","family":"Taylor","sequence":"first","affiliation":[{"name":"Senior Consultant, York Health Economics Consortium Ltd, University of York, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Scuffham","sequence":"additional","affiliation":[{"name":"Associate Senior Consultant, York Health Economics Consortium, University of York, UK"},{"name":"Professor of Health Economics, School of Medicine, Griffith University, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick L.","family":"McCollam","sequence":"additional","affiliation":[{"name":"Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Newby","sequence":"additional","affiliation":[{"name":"Professor of Cardiology and Consultant Cardiologist, University of Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2007,2,6]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02489-X"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2610"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2002.3193"},{"key":"CIT0004","unstructured":"OECD Economic Outlook 76 Database. OECD. http:\/\/www. oecd.org\/document\/61\/0,2340,en_2825_32066506_2483901_ 1_1_1_1,00.html . 2004. 1\u20133\u20132005. [Last accessed 7 Nov 2006]"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"In TIME II Investigators. Geographic variation in patient, and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Eur Heart J 2001;22:1702\u201315","DOI":"10.1053\/euhj.2001.2583"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.3081"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1136\/heart.85.2.121"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00315-4"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2185"},{"key":"CIT0010","first-page":"1","author":"Dickson M","year":"2003","journal-title":"OECD Health Working Paper"},{"key":"CIT0011","unstructured":"Department of Health. Reference Costs 2002. London: Department of Health, 2003"},{"key":"CIT0012","unstructured":"Agence Technique de l\u2019Information sur l\u2019Hospitalisation. Echelle nationale des co\u00fbts relatifs par GHM. France, 2003"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200018010-00009"},{"key":"CIT0014","first-page":"13","volume":"2003","author":"G-DRG","year":"2004","journal-title":"Fallpauschalenverordnung 2004 \u2013 KFPV"},{"key":"CIT0015","unstructured":"G-DRG Group. G-DRG Version 2004: Fallpauschalenkatalog f\u00fcr Hauptabteilungen bzw. Belegabteilungen. In Klauber J, Robra B-P, Schellschmidt H, eds. Krankenhaus-Report 2003. Stuttgart: Schattauer, 2004"},{"key":"CIT0016","unstructured":"Consejo General de Colegios Oficiales de Farmaceuticos. Consumer price PVP. Spain, 2003"},{"key":"CIT0017","unstructured":"Reverte D, Moreno JJ, Ferreira EM. Hipertension Arterial: Actualizacion de su tratamiento. Informacion Terapeutica del Sistema Nacional de Salud, Spain, 1998;22"},{"key":"CIT0018","unstructured":"Blasco A, Gonzalez A, Lobos JM, Silva L. Tratamiento medico de la angina estable: farmacos antianginosos y prevencion secundaria de la cardiopatia isquemica. Informacion Terapeutica del Sistema Nacional de Salud, Spain, 2003;27"},{"key":"CIT0019","first-page":"659","volume":"6","author":"Danchin N","year":"2003","journal-title":"Economic analysis of the use of contrast media during percutaneous coronary intervention (PCI) in France and Spain. Value in Health"},{"key":"CIT0020","unstructured":"British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary 46, 2003. London: Royal Pharmaceutical Society of Great Britain"},{"key":"CIT0021","unstructured":"Department of Health. Prescription Cost Analysis 2002. London, 2002"},{"key":"CIT0022","unstructured":"Sanitaria Farmaceutica. Giofil 2003, 2003. Italy. Report"},{"key":"CIT0023","unstructured":"Assurance Maladie en Ligne. Guide des \u00e9quivalents th\u00e9rapeutiques. France, 2003"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Schwabe U, Paffrath D. Arzneiverordnungs Report 2003. Berlin: Springer, 2003","DOI":"10.1007\/978-3-642-18512-0"},{"key":"CIT0025","volume-title":"University of Kent","author":"Netten A","year":"2002"},{"key":"CIT0026","first-page":"848","volume":"89","author":"Stewart S","year":"2003","journal-title":"et al. The current cost of angina pectoris to the National Health Service in the UK. Heart"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1136\/heart.88.6.597"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(05)70219-4"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1093\/her\/11.4.487"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/76.5.456"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01512-1"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(03)00077-X"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(97)00015-8"},{"key":"CIT0034","unstructured":"World Population Database. United Nations 2002. 15\u201311\u20132003. [Last accessed 7 Nov 2006]"},{"key":"CIT0035","first-page":"3","author":"Moise P","year":"2003","journal-title":"OECD Health Working Paper"},{"key":"CIT0036","doi-asserted-by":"crossref","unstructured":"Marques-Vidal P, Ruidavets JB, Cambou JP, Ferri\u00e8res J. Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993. Heart 2000;84: 171\u20135","DOI":"10.1136\/heart.84.2.171"},{"key":"CIT0037","first-page":"3","author":"Working Party on Social Policy","year":"2002","journal-title":"OECD Workshop"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2002.3187"},{"key":"CIT0039","unstructured":"BCIS Audit Returns 2001. British Cardiovascular Intervention Society 2002. 11\u201311\u20132003. [Last accessed 7 Nov 2006]"},{"key":"CIT0040","unstructured":"Department of Health. Prescription Cost Analysis 2002. London, 2002"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X167462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T13:28:11Z","timestamp":1599312491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X167462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3,1]]}},"alternative-id":["10.1185\/030079906X167462"],"URL":"https:\/\/doi.org\/10.1185\/030079906x167462","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,6]]}}}